Peter rossing :Firstly some non-diabetic kidney diseases need specific treatment such as immunosuppressive therapy.

其二，二预不同，与糖尿病肾病相比，某些糖尿病肾病的预很好。

Mixed uremic osteodystrophy was found in 7 patients (12.3%), adynamic renal bone disease in 3 patients (5.3%), and osteomalacia in 2 patients (3.5%).

7名患（12.3%）为混合性肾病性骨营养不良症，3名患（5.3%）为骨再生不良，2名患（3.5%）为骨软化。

Mild osteitis fibrosa and osteitis fibrosa, the most frequent forms of renal osteodystrophy, were observed in 13. (22.8%) and 14 patients (24.6%), respectively.

轻度纤维性骨炎和纤维性骨炎是肾病性骨营养不良最见的形式，分别有13名患（22.8%）和14名患（24.6%）出现以上两种疾病。

Rhein,a main constituent of rhubarb, is a well-characterized anti-inflammatory agent with recognized utility in a range of inflammatory diseases such as ostarthritis, diabetic nephropathy etc.

是中药的主要成分之一,临床可用于治疗骨关节炎、糖尿病肾病等疾病,并且具有协同抗肿瘤的作用。

Peter rossing :Firstly some non-diabetic kidney diseases need specific treatment such as immunosuppressive therapy.

其二，二预后非常不同，与糖相比，某些非糖的预后很好。

Mixed uremic osteodystrophy was found in 7 patients (12.3%), adynamic renal bone disease in 3 patients (5.3%), and osteomalacia in 2 patients (3.5%).

7患（12.3%）为混合性性骨营养不良症，3患（5.3%）为骨再生不良，2患（3.5%）为骨软化。

Mild osteitis fibrosa and osteitis fibrosa, the most frequent forms of renal osteodystrophy, were observed in 13. (22.8%) and 14 patients (24.6%), respectively.

轻度纤维性骨炎和纤维性骨炎是性骨营养不良最常见的形式，分有13患（22.8%）和14患（24.6%）出现以上两种疾。

Rhein,a main constituent of rhubarb, is a well-characterized anti-inflammatory agent with recognized utility in a range of inflammatory diseases such as ostarthritis, diabetic nephropathy etc.

大黄酸是中药大黄的主要成分之一,临床可用于治疗骨关节炎、糖等疾,并且具有协同抗肿瘤的作用。

Peter rossing :Firstly some non-diabetic kidney diseases need specific treatment such as immunosuppressive therapy.

其二，二预后非常不同，与糖尿病肾病相比，某些非糖尿病肾病的预后很好。

Mixed uremic osteodystrophy was found in 7 patients (12.3%), adynamic renal bone disease in 3 patients (5.3%), and osteomalacia in 2 patients (3.5%).

7名患（12.3%）为混合性肾病性骨营养不良症，3名患（5.3%）为骨再生不良，2名患（3.5%）为骨软化。

Mild osteitis fibrosa and osteitis fibrosa, the most frequent forms of renal osteodystrophy, were observed in 13. (22.8%) and 14 patients (24.6%), respectively.

轻度纤维性骨炎和纤维性骨炎是肾病性骨营养不良最常见的形式，分别有13名患（22.8%）和14名患（24.6%）出现以上两种疾病。

Rhein,a main constituent of rhubarb, is a well-characterized anti-inflammatory agent with recognized utility in a range of inflammatory diseases such as ostarthritis, diabetic nephropathy etc.

大黄酸是中药大黄的主要成分之,可用于治疗骨关节炎、糖尿病肾病等疾病,并且具有协同抗肿瘤的作用。

Peter rossing :Firstly some non-diabetic kidney diseases need specific treatment such as immunosuppressive therapy.

其二，二预后非常不同，与糖尿病肾病相比，某些非糖尿病肾病的预后很好。

Mixed uremic osteodystrophy was found in 7 patients (12.3%), adynamic renal bone disease in 3 patients (5.3%), and osteomalacia in 2 patients (3.5%).

7名患（12.3%）为肾病养不良症，3名患（5.3%）为再生不良，2名患（3.5%）为软化。

Mild osteitis fibrosa and osteitis fibrosa, the most frequent forms of renal osteodystrophy, were observed in 13. (22.8%) and 14 patients (24.6%), respectively.

轻度纤维炎和纤维炎是肾病养不良最常见的形式，分别有13名患（22.8%）和14名患（24.6%）出现以上两种疾病。

Rhein,a main constituent of rhubarb, is a well-characterized anti-inflammatory agent with recognized utility in a range of inflammatory diseases such as ostarthritis, diabetic nephropathy etc.

大黄酸是中药大黄的主要成分之一,临床可用于治疗关节炎、糖尿病肾病等疾病,并且具有协同抗肿瘤的作用。

Peter rossing :Firstly some non-diabetic kidney diseases need specific treatment such as immunosuppressive therapy.

其二，二预后非常不同，与糖尿病肾病相比，某些非糖尿病肾病的预后很好。

Mixed uremic osteodystrophy was found in 7 patients (12.3%), adynamic renal bone disease in 3 patients (5.3%), and osteomalacia in 2 patients (3.5%).

7名患（12.3%）混合性肾病性营养不良症，3名患（5.3%）生不良，2名患（3.5%）软化。

Mild osteitis fibrosa and osteitis fibrosa, the most frequent forms of renal osteodystrophy, were observed in 13. (22.8%) and 14 patients (24.6%), respectively.

轻性炎和性炎是肾病性营养不良最常见的形式，分别有13名患（22.8%）和14名患（24.6%）出现以上两种疾病。

Rhein,a main constituent of rhubarb, is a well-characterized anti-inflammatory agent with recognized utility in a range of inflammatory diseases such as ostarthritis, diabetic nephropathy etc.

大黄酸是中药大黄的主要成分之一,临床可用于治疗关节炎、糖尿病肾病等疾病,并且具有协同抗肿瘤的作用。

Peter rossing :Firstly some non-diabetic kidney diseases need specific treatment such as immunosuppressive therapy.

其，预后非常不同，与糖尿病肾病相比，某些非糖尿病肾病的预后很好。

Mixed uremic osteodystrophy was found in 7 patients (12.3%), adynamic renal bone disease in 3 patients (5.3%), and osteomalacia in 2 patients (3.5%).

7名患（12.3%）为混合性肾病性骨营养不良症，3名患（5.3%）为骨再生不良，2名患（3.5%）为骨软化。

Mild osteitis fibrosa and osteitis fibrosa, the most frequent forms of renal osteodystrophy, were observed in 13. (22.8%) and 14 patients (24.6%), respectively.

轻度纤维性骨炎和纤维性骨炎是肾病性骨营养不良最常见的形式，分别有13名患（22.8%）和14名患（24.6%）出现以上两种疾病。

Rhein,a main constituent of rhubarb, is a well-characterized anti-inflammatory agent with recognized utility in a range of inflammatory diseases such as ostarthritis, diabetic nephropathy etc.

黄酸是黄的主要成分之一,临床可用于治疗骨关节炎、糖尿病肾病等疾病,并且具有协同抗肿瘤的作用。

Peter rossing :Firstly some non-diabetic kidney diseases need specific treatment such as immunosuppressive therapy.

其二，二预后非常不同，与糖尿病肾病，些非糖尿病肾病的预后很好。

Mixed uremic osteodystrophy was found in 7 patients (12.3%), adynamic renal bone disease in 3 patients (5.3%), and osteomalacia in 2 patients (3.5%).

7（12.3%）为混合性肾病性骨营养不良症，3（5.3%）为骨再生不良，2（3.5%）为骨软化。

Mild osteitis fibrosa and osteitis fibrosa, the most frequent forms of renal osteodystrophy, were observed in 13. (22.8%) and 14 patients (24.6%), respectively.

轻度纤维性骨炎和纤维性骨炎是肾病性骨营养不良最常见的形式，分别有13（22.8%）和14（24.6%）出现以上两种疾病。

Rhein,a main constituent of rhubarb, is a well-characterized anti-inflammatory agent with recognized utility in a range of inflammatory diseases such as ostarthritis, diabetic nephropathy etc.

大黄酸是中药大黄的主要成分之一,临床可用于治疗骨关节炎、糖尿病肾病等疾病,并且具有协同抗肿瘤的作用。

Peter rossing :Firstly some non-diabetic kidney diseases need specific treatment such as immunosuppressive therapy.

其二，二预后非常不同，与糖尿病肾病相比，某些非糖尿病肾病的预后很好。

Mixed uremic osteodystrophy was found in 7 patients (12.3%), adynamic renal bone disease in 3 patients (5.3%), and osteomalacia in 2 patients (3.5%).

7（12.3%）为混合肾病营养不良症，3（5.3%）为再生不良，2（3.5%）为软化。

Mild osteitis fibrosa and osteitis fibrosa, the most frequent forms of renal osteodystrophy, were observed in 13. (22.8%) and 14 patients (24.6%), respectively.

轻度纤维和纤维是肾病营养不良最常见的形式，分别有13（22.8%）和14（24.6%）出现以上两种疾病。

Rhein,a main constituent of rhubarb, is a well-characterized anti-inflammatory agent with recognized utility in a range of inflammatory diseases such as ostarthritis, diabetic nephropathy etc.

大黄酸是中药大黄的主要成分之一,临床可用于治疗关节、糖尿病肾病等疾病,并且具有协同抗肿瘤的作用。

Peter rossing :Firstly some non-diabetic kidney diseases need specific treatment such as immunosuppressive therapy.

其二，二预后非常同，与糖尿病肾病相比，某些非糖尿病肾病的预后很好。

Mixed uremic osteodystrophy was found in 7 patients (12.3%), adynamic renal bone disease in 3 patients (5.3%), and osteomalacia in 2 patients (3.5%).

7名患（12.3%）为混合性肾病性骨营养良症，3名患（5.3%）为骨良，2名患（3.5%）为骨软。

Mild osteitis fibrosa and osteitis fibrosa, the most frequent forms of renal osteodystrophy, were observed in 13. (22.8%) and 14 patients (24.6%), respectively.

纤维性骨炎和纤维性骨炎是肾病性骨营养良最常见的形式，分别有13名患（22.8%）和14名患（24.6%）出现以上两种疾病。

Rhein,a main constituent of rhubarb, is a well-characterized anti-inflammatory agent with recognized utility in a range of inflammatory diseases such as ostarthritis, diabetic nephropathy etc.

大黄酸是中药大黄的主要成分之一,临床可用于治疗骨关节炎、糖尿病肾病等疾病,并且具有协同抗肿瘤的作用。

Peter rossing :Firstly some non-diabetic kidney diseases need specific treatment such as immunosuppressive therapy.

其二，二预后非常不同，与糖尿相比，某些非糖尿的预后很好。

Mixed uremic osteodystrophy was found in 7 patients (12.3%), adynamic renal bone disease in 3 patients (5.3%), and osteomalacia in 2 patients (3.5%).

7名患（12.3%）为混合性性骨营养不良症，3名患（5.3%）为骨再生不良，2名患（3.5%）为骨软化。

Mild osteitis fibrosa and osteitis fibrosa, the most frequent forms of renal osteodystrophy, were observed in 13. (22.8%) and 14 patients (24.6%), respectively.

轻度纤维性骨炎和纤维性骨炎是性骨营养不良最常见的形式，分别有13名患（22.8%）和14名患（24.6%）上两种疾。

Rhein,a main constituent of rhubarb, is a well-characterized anti-inflammatory agent with recognized utility in a range of inflammatory diseases such as ostarthritis, diabetic nephropathy etc.

大黄酸是中药大黄的主要成分之一,临床可用于治疗骨关节炎、糖尿等疾,并且具有协同抗肿瘤的作用。